Concepedia

Inna Vainshtein

IV

18

Publications

594

Citations

14

H-Index

1996

Active since

Affiliations

Institute of Neuroimmunology of the Slovak Academy of Sciences(Current)

AstraZeneca (United States)

Takeda (United States)

Incyte (United States)

Pfizer (Canada)

Inna Vainshtein is an author at Institute of Neuroimmunology of the Slovak Academy of Sciences specializing in immunology, medicine, and immunotherapy.

ORCID

Top concepts

Publications per year

1996–2023

18

Publications

18

Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus

Jeffrey M. Riggs, Richard N. Hanna, Bhargavi Rajan et al. · Lupus Science & Medicine · 2018 · 139 citations · Full text

Molecular Mechanism of HER2 Rapid Internalization and Redirected Trafficking Induced by Anti-HER2 Biparatopic Antibody

Jackie Cheng, Meina Liang, Miguel F. Carvalho et al. · Antibodies · 2020 · 55 citations · Full text

, , +22

Pharmacogenomics and Translational Simulations to Bridge Indications for an Anti-Interferon-α Receptor Antibody

B Wang, Brandon W. Higgs, Linda Chang et al. · Clinical Pharmacology & Therapeutics · 2013 · 54 citations · Full text

A High-Throughput, Nonisotopic, Competitive Binding Assay for Kinases Using Nonselective Inhibitor Probes (ED-NSIP™)

Inna Vainshtein, Scott Silveria, Poonam Kaul et al. · SLAS DISCOVERY · 2002 · 40 citations · Full text

Quantitative Measurement of the Target-Mediated Internalization Kinetics of Biopharmaceuticals

Inna Vainshtein, Lorin Roskos, Jackie Cheng et al. · Pharmaceutical Research · 2014 · 39 citations · Full text

Rows per page

1–5 of 18